Sintetica establishes US entity
Mendrisio, Switzerland (ots/PRNewswire) - Sintetica, a Swiss pharmaceutical company headquartered in Mendrisio specializing in injectables in the field of pain therapy, has taken another important and significant step in its 100-year growth strategy. On July 14, 2022 Sintetica established its subsidiary Sintetica US, headquartered in Princeton, New Jersey, headed by leading pharma expert Frank Mullery (President-Sintetica US). Frank Mullery brings with him more than 20 years ...
mehr